Search

everythinglearnresearchcommunity

for

Search:↓

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

New cancer treatments aim to reduce side effects and improve effectiveness.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

A group has developed therapies that show promise for treating cancer and various other conditions.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.